Alvalux Medical SA

A leading Belgian therapeutic wearables company in global expansion mode

• First product CicaLux – researched, developed and launched.
• CE Mark and US FDA registrations achieved.
• First €3M in contract sales signed in 10 countries.
• Earned 4 product awards in France, UK, and USA.
• Complementary product pipeline with IP,  >€60 billion market size.
• Teamed with Dupont-Dow and UCL-Université catholique de Louvain.
• Strong and efficient USA-EU experienced management team. 
• USA subsidiary established and ready for growth.

Seeking funds to fuel sales growth in the USA - our largest market. 

€1.5 - 2.5M lead investor sought to match Noshaq and SRIW in our 3-5m Series A round.

Please visit www.alvalux.com and www.cicalux.com for more info and videos.